robert a. figlin, md, on how checkpoint inhibitors figure into treatment for 1st line rcc patients
Published 6 years ago • 13 plays • Length 0:52Download video MP4
Download video MP3
Similar videos
-
18:11
immunotherapy robert a. figlin, m.d.
-
0:53
dr. figlin on advances in immunotherapy for kidney cancer
-
1:10
robert filgin md provides an update on nivolumab (opdivo) in rcc
-
5:33
cancer immune checkpoint inhibitors
-
1:25
dr. figlin on ongoing adapt trial for mrcc
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
10:27
immunotherapy for cancer treatment: new hope or more hype?
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
4:27
the role of immune checkpoint inhibitors in mds
-
11:50
update on immunotherapy for glioblastoma - robert prins, ph.d.
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
1:49
dr. sosman on checkpoint inhibitors in cancer care
-
8:39
bezos family immunotherapy clinic: what to expect
-
6:57
immunotherapy - checkpoint inhibitors: overview and clinical applications
-
38:56
michael cancro: b cell selection and survival: first order considerations for immunogenicity
-
0:58
what are immune checkpoints?
-
1:53
new treatment approaches for merkel cell carcinoma - checkpoint inhibitors
-
0:47
bo-112: enhancing immune-checkpoint inhibition in solid tumors
-
44:33
immunotherapy symposium - the birth of "ipi" and discovery of pd-1 antibodies
-
1:43
ask ruby: what are checkpoint inhibitors?
-
5:24
the hunt for new checkpoint inhibitors - amgen science
-
1:50
what are 'checkpoint' immunotherapy drugs? | immunotherapy | cancer research uk